{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Merck & Company will pay $1.1 billion to acquire Sirna Therapeutics, one of the leading companies pursuing technology to inactivate particular genes.", "headline": {"main": "Merck Buys Maker of Gene-Silencing Drugs", "print_headline": "Merck Buys Maker of Gene-Silencing Drugs"}, "abstract": null, "print_page": "3", "word_count": "569", "_id": "54a5aab77988102023c949c4", "snippet": "Merck & Company will pay $1.1 billion to acquire Sirna Therapeutics, one of the leading companies pursuing technology to inactivate particular genes.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/10/31/business/31drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Merck & Company Inc", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Sirna Therapeutics Incorporated", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Genetics and Heredity", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Science and Technology", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Biotechnology", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "8", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2006-10-31T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial", "lead_paragraph": "The idea of having calories listed alongside prices at fast food chains makes sense.", "headline": {"main": "Making Meals Count in New York", "print_headline": "Making Meals Count in New York", "content_kicker": "Editorial"}, "abstract": null, "print_page": "24", "word_count": "245", "_id": "54a5a9f37988102023c949b3", "snippet": "The idea of having calories listed alongside prices at fast food chains makes sense.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/10/31/opinion/31tue4.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Fast Food Industry", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Diet and Nutrition", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "New York City", "is_major": "N", "rank": "4", "name": "glocations"}, {"value": "Restaurants", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Obesity", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Bloomberg, Michael R", "is_major": "N", "rank": "7", "name": "persons"}, {"value": "Frieden, Thomas R", "is_major": "N", "rank": "8", "name": "persons"}, {"value": "Medicine and Health", "is_major": "N", "rank": "9", "name": "subject"}], "byline": null, "document_type": "article", "pub_date": "2006-10-31T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Calorie-restricted diets, which involve eating about 30 percent fewer calories than normal, can extend life consistently in a variety of animal species.", "headline": {"main": "One for the Ages: A Prescription That May Extend Life", "print_headline": "One for the Ages: A Prescription That May Extend Life"}, "abstract": null, "print_page": "1", "word_count": "2579", "_id": "54a5a4987988102023c948e3", "snippet": "Calorie-restricted diets, which involve eating about 30 percent fewer calories than normal, can extend life consistently in a variety of animal species.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/10/31/health/nutrition/31agin.html", "multimedia": [{"subtype": "wide", "url": "images/2006/10/31/health/31aging_graphic_190.jpg", "height": 122, "width": 190, "legacy": {"wide": "images/2006/10/31/health/31aging_graphic_190.jpg", "wideheight": "122", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2006/10/30/science/aging.5.600.jpg", "height": 275, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2006/10/30/science/aging.5.600.jpg", "xlargeheight": "275"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2006/10/30/science/aging.5.7575.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/10/30/science/aging.5.7575.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Fitness & Nutrition", "keywords": [{"value": "Food", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Age, Chronological", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Michael", "lastname": "MASON"}], "original": "By MICHAEL MASON"}, "document_type": "article", "pub_date": "2006-10-31T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Having cancer was hard enough. A gene test meant the chance of more bad news. ", "headline": {"main": "In Breast Cancer, There Is a Single Agenda: Stay Alive", "kicker": "Cases", "print_headline": "In Breast Cancer, There is a Single Agenda: Stay Alive", "content_kicker": "Cases"}, "abstract": null, "print_page": "5", "word_count": "1051", "_id": "54a58bd67988102023c9412e", "snippet": "Having cancer was hard enough. A gene test meant the chance of more bad news.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/10/31/health/31case.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2006/10/30/health/case.7575.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2006/10/30/health/case.7575.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Cancer", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Breast", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mammography", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Genetics and Heredity", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Aliyah", "lastname": "BARUCHIN"}], "original": "By ALIYAH BARUCHIN"}, "document_type": "article", "pub_date": "2006-10-31T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Merck & Company will pay $1.1 billion to acquire Sirna Therapeutics, one of the leading companies pursuing the technology that was the basis for the Nobel Prize in medicine awarded earlier this month. The deal, announced by the companies yesterday after the close of trading, is the largest sign yet of interest among pharmaceutical companies in the technology, known as RNA interference. Merck's all-cash offer for Sirna was worth $13 a share, more than double Sirna's $6.45 closing price yesterday.", "headline": {"main": "Merck Buys Maker of Gene-Silencing Drugs"}, "abstract": "Merck & Co will pay $1.1 billion to acquire Sirna Therapeutics, one of leading companies pursuing RNA interference technology; RNAi is used widely in laboratories to study functions of genes; Merck and Sirna hope technique may also be used one day to treat diseases by turning off their genes (M)", "print_page": "3", "word_count": 569, "_id": "4fd279618eb7c8105d83c6f0", "snippet": "Merck & Company will pay $1.1 billion to acquire Sirna Therapeutics, one of the leading companies pursuing the technology that was the basis for the Nobel Prize in medicine awarded earlier this month.      The deal, announced by the companies...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C00E1DB123FF932A05753C1A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "SIRNA THERAPEUTICS"}, {"name": "organizations", "value": "MERCK & CO"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "RNA (RIBONUCLEIC ACID)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2006-10-31T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "Alcoholism, coupled with poisoning by low-quality and bootleg liquor, remains one of post-Soviet Russia\u2019s most serious problems.", "headline": {"main": "Deaths From Alcohol Are Sweeping Russia", "print_headline": "Deaths From Alcohol Are Sweeping Russia"}, "abstract": null, "print_page": "12", "word_count": "171", "_id": "54a598f37988102023c94553", "snippet": "Alcoholism, coupled with poisoning by low-quality and bootleg liquor, remains one of post-Soviet Russia\u2019s most serious problems.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/10/29/world/europe/29russia.html", "multimedia": [], "subsection_name": "Europe", "keywords": [{"value": "Russia", "is_major": "N", "rank": "1", "name": "glocations"}, {"value": "Alcoholic Beverages", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Poisoning and Poisons", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2006-10-29T00:00:00Z", "section_name": "World"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "To the Editor:.", "headline": {"main": "Preparedness and a Flu Epidemic (5 Letters)", "print_headline": "Preparedness and a Flu Epidemic"}, "abstract": null, "print_page": "11", "word_count": "756", "_id": "54a5902b7988102023c94293", "snippet": "To the Editor:.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2006/10/29/opinion/l29flu.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Influenza", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "SARS (Severe Acute Respiratory Syndrome)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Vaccination and Immunization", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Masks", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Miyake, Issey", "is_major": "N", "rank": "6", "name": "persons"}, {"value": "Health and Human Services Department", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "CARE", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Health Department", "is_major": "N", "rank": "9", "name": "organizations"}], "byline": null, "document_type": "article", "pub_date": "2006-10-29T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: ''Face Facts,'' by Lawrence M. Wein (Op-Ed, Oct. 25), did not mention many facts about the government's commitment to flu pandemic preparedness. The Department of Health and Human Services has made significant investments to buy N95 respirators, surgical masks and antiviral stockpiles, expand vaccine manufacturing capabilities, improve monitoring and surveillance, support state and local preparedness and many other activities.", "headline": {"main": "Preparedness and a Flu Epidemic"}, "abstract": "Five letters comment on Prof Lawrence M Wein's Oct 25 Op-Ed article on flu epidemic preparedness; Dr John O Agwunobi, Health and Human Services official, says government is buying necessary respirators and countermeasures to protect public health in event of flu epidemic; Dr Marc Siegel disagrees with Wein that flu pandemic is looming and says paper surgical masks spread fear rather than contain virus; Kyle Kinner says preparing for pandemic in developing world is most important way to strengthen US health security; Dai-En Bennage says paper masks are start and are already used in countries like Japan; Linda Jessen disagrees that government should stockpile face protectors and says people should obtain their own; drawing", "print_page": "11", "word_count": 752, "_id": "4fd253078eb7c8105d7f8e51", "snippet": "To the Editor:     ''Face Facts,'' by Lawrence M. Wein (Op-Ed, Oct. 25), did not mention many facts about the government's commitment to flu pandemic preparedness.      The Department of Health and Human Services has made significant investments to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C0DE4D9153FF93AA15753C1A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SIEGEL, MARC"}, {"name": "persons", "value": "JESSEN, LINDA"}, {"name": "persons", "value": "KINNER, KYLE"}, {"name": "persons", "value": "WEIN, LAWRENCE M"}, {"name": "persons", "value": "AGWUNOBI, JOHN"}, {"name": "persons", "value": "BENNAGE, DAI-EN"}, {"name": "subject", "value": "INFLUENZA"}, {"name": "subject", "value": "MASKS"}, {"name": "subject", "value": "RESPIRATORS"}, {"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": null, "document_type": "article", "pub_date": "2006-10-29T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 8, "offset": 0, "time": 53}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}